Saeid Esmaeilzadeh, Ph.D.
Born in 1974. Member of the Board since 2013. Chairman of the remuneration committee and member of the audit committee.
Education and relevant experience:
Saeid Esmaeilzadeh holds a Ph.D. in Chemistry from the Stockholm University. Saeid Esmaeilzadeh has been rewarded several awards for research and entrepreneurial accomplishments. He is the founder of several innovative companies within MedTech, Industrials and CleanTech.
Other current assignments:
Chairman of the board of Xbrane Biopharma AB, Serendipity Ixora AB (publ), Premuna AB (publ) and S. Professionals AB. Board member in Diamorph AB (publ), Sdiptech AB (publ), Episurf Medical AB, Serendipity Group AB, Swecure AB (publ), Nextseal AB, Build-r AB, Nextmune MC AB, Nextmune HoldCo AB and Nextmune AB. Deputy board member of Serendip Invest AB, VZL Vilande AB, Auremune AB, Leonova CONSULTING AB, Premune IPR AB, Swecure Europe AB, Intelligent Art AB, Swecure IPR AB, Serendipity Innovations AB, DynaSeal LCT AB and Serendipity Ventures AB.
Shareholding in IRRAS: 2 137 561 shares via Serendipity Group AB and Serendipity Ixora AB
Saeid Esmaeilzadeh is independent in relation to the company and its management but not in relation to its major shareholders